BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development

World News: . []

Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in Pharmaceuticals and Regenerative Medicine, announced today the addition of Dr. Felix Amon, who will consult BSEM with Pharmaceutical Business Development.

Dr. Felix Amon has two decades of product management, medical innovation and business development experience in healthcare and related industries, including three years as a Product Manager for Eli Lilly, 2 years as as the Austria Marketing and Sales Director for Merck (MSD) Europe, followed by leading the Ophthalmics business in Merck’s ww Headquarter in Whitehouse Station, New Jersey where he managed Planning and Project Management for a $650 million business operating in 104 countries. He also completed the development of an European Sales and Marketing Campaign for BIOGEN’s Avonex and implemented the launch of Avonex in Germany, Austria and Switzerland. Dr. Amon has an MBA (1987) from Emory University in Atlanta, Georgia, and a PhD in Law (1985) from Linz – Johannes Keppler University in Austria.

BSEM’s, COO, Andrew Van Vurst stated, “The addition of Dr. Amon to our team is imperative in the Companies’ mission to discover, develop and market novel Pharmaceutical and Regenerative Medicine products. We look forward to leveraging his experience in the development of sales and marketing strategies for BioStem Technologies pharmaceutical portfolio.”   

BioStem Technologies, Inc.
Phone: 954-380-8342
Twitter: @Biostemtech
Facebook: BioStem Technologies

Investor Relations:
Andrew Van Vurst
(954) 380-8342

More news and information about BioStem Technologies, Inc.

Published By:

Globe Newswire: 22:16 GMT Tuesday 13th March 2018

Published: .

Search for other references to "biostem" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers